FR2517M - Compositions pharmaceutiques contenant des propanolamines. - Google Patents

Compositions pharmaceutiques contenant des propanolamines.

Info

Publication number
FR2517M
FR2517M FR42830A FR69042830A FR2517M FR 2517 M FR2517 M FR 2517M FR 42830 A FR42830 A FR 42830A FR 69042830 A FR69042830 A FR 69042830A FR 2517 M FR2517 M FR 2517M
Authority
FR
France
Prior art keywords
propanolamines
pharmaceutical compositions
compositions containing
pharmaceutical
containing propanolamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR42830A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Priority to FR42830A priority Critical patent/FR2517M/fr
Application granted granted Critical
Publication of FR2517M publication Critical patent/FR2517M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR42830A 1961-05-19 1962-08-17 Compositions pharmaceutiques contenant des propanolamines. Active FR2517M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR42830A FR2517M (fr) 1961-05-19 1962-08-17 Compositions pharmaceutiques contenant des propanolamines.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB18380/61A GB993525A (en) 1961-05-19 1961-05-19 Substituted propanolamines and process for preparing the same
FR42601A FR1383731A (fr) 1961-05-19 1962-05-18 Procédé de préparation de propanolamines
FR42830A FR2517M (fr) 1961-05-19 1962-08-17 Compositions pharmaceutiques contenant des propanolamines.

Publications (1)

Publication Number Publication Date
FR2517M true FR2517M (fr) 1964-05-11

Family

ID=10111467

Family Applications (2)

Application Number Title Priority Date Filing Date
FR42601A Expired FR1383731A (fr) 1961-05-19 1962-05-18 Procédé de préparation de propanolamines
FR42830A Active FR2517M (fr) 1961-05-19 1962-08-17 Compositions pharmaceutiques contenant des propanolamines.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR42601A Expired FR1383731A (fr) 1961-05-19 1962-05-18 Procédé de préparation de propanolamines

Country Status (3)

Country Link
US (1) US3190920A (fr)
FR (2) FR1383731A (fr)
GB (1) GB993525A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1149002B (de) * 1961-10-19 1963-05-22 Giulini Gmbh Geb Verfahren zur Herstellung von blutdrucksteigernden Salzen von N, N-Dialkyl-2-aethyl-3, 3-diphenyl-propen-(2)-yl-aminen
US3317380A (en) * 1965-03-19 1967-05-02 Upjohn Co Process for inducing anorexia
US3506670A (en) * 1966-09-26 1970-04-14 Upjohn Co 2-hetero-amino-alpha,alpha-diaryl-cycloalkone-methanols and esters thereof
BE793548A (fr) * 1971-12-30 1973-04-16 Whitefin Holding Sa Derive du propoxyphene et sa preparation
US3962243A (en) * 1973-09-12 1976-06-08 Laboratories Made, S.A. Mepyramine theophylline acetate
GB1489989A (en) * 1974-03-04 1977-10-26 Temmler Ag Alpha,alpha-diaryl-beta-(tert-amino)-propanols processes for their preparation and pharmaceutical compositions containing them
US4361573A (en) * 1974-03-04 1982-11-30 Temmler Ag α,α-Diaryl-β-(tert-amino)-propanols and diuretic pharmaceutical compositions containing them
JPS60132934A (ja) * 1983-11-21 1985-07-16 Nippon Shinyaku Co Ltd ブタノ−ル誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA525752A (fr) * 1956-06-05 V. Petersen Poul Amines tertiaires non saturees antispasmodiques
GB815217A (en) * 1957-12-03 1959-06-17 Bayer Ag 1-o-chlorophenyl-1-phenyl-3-(dimethylamino)-propan-1-ol and its salts and therapeuticcompositions containing them
GB627139A (en) * 1947-05-28 1949-07-29 Wellcome Found Improvements in and relating to the preparation of quaternary ammonium salts of substituted propanolamines, allylamines and propylamines
US2835676A (en) * 1953-07-14 1958-05-20 Merck & Co Inc Gamma-keto-tertiary amines and derivatives thereof
DE1111208B (de) * 1957-07-18 1961-07-20 Hoechst Ag Verfahren zur Herstellung von hustenreizstillend wirkenden, basisch substituierten Diphenylcarbinolestern

Also Published As

Publication number Publication date
US3190920A (en) 1965-06-22
FR1383731A (fr) 1965-01-04
GB993525A (en) 1965-05-26

Similar Documents

Publication Publication Date Title
FR2144M (fr) Compositions pharmaceutiques contenant des sources radioactives.
FR2517M (fr) Compositions pharmaceutiques contenant des propanolamines.
FR3250M (fr) Compositions anti-déprimantes.
BE622943A (fr) Compositions thérapeutiques, contenant des dérivés d'émétine.
FR1815M (fr) Produit analgésique.
FR1349561A (fr) Feuilles contenant des capsules
FR3383M (fr) Dérivés du camphene-phénol et compositions pharmaceutiques les contenant.
FR2448M (fr) Composé de la classe des 2-amino-5-aryl-oxazolines et compositions pharmaceutiques le contenant.
FR1306648A (fr) Composition désinfectante
FR2557M (fr) Composition pharmaceutique.
FR1041M (fr) Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one.
FR2156M (fr) Nouvelles compositions thérapeutiques.
FR1373M (fr) Composition thérapeutique.
FR3376M (fr) Compositions pharmaceutiques contenant des dérivés de la quinoléine.
BE585967A (fr) Compositions pharmaceutiques contenant des dérivés de la benzylhydrazine.
FR1271M (fr) Nouvelles compositions pharmaceutiques.
FR1702M (fr) Composition pharmaceutique active contre la toux.
FR3054M (fr) Préparations pharmaceutiques.
FR2260M (fr) Dérivés de la 16 alpha-chloroprednisolone et compositions thérapeutiques en contenant.
FR2985M (fr) Compositions pharmaceutiques contenant des dérivés de l'indole.
FR3265M (fr) Diluant pharmaceutique.
FR3492M (fr) Composition médicamenteuse antiprotéolytique.
FR2954M (fr) Compositions aqueuses pharmaceutiques stérilisées in situ.
AT248795B (de) Parasitizide Zusammensetzungen
FR2620M (fr) Nouvel antibiotique et compositions le contenant.